Integrated Analyses for Genetic Markers of Polycystic Ovary Syndrome with 9 Case-Control Studies of Gene Expression Profiles

Chenqi Lu,Xiaoqin Liu,Lin Wang,Ning Jiang,Jun Yu,Xiaobo Zhao,Hairong Hu,Saihua Zheng,Xuelian Li,Guiying Wang

DOI: https://doi.org/10.18632/oncotarget.13881

2016-01-01

Oncotarget

Abstract:Due to genetic heterogeneity and variable diagnostic criteria, genetic studies of polycystic ovary syndrome are particularly challenging. Furthermore, lack of sufficiently large cohorts limits the identification of susceptibility genes contributing to polycystic ovary syndrome. Here, we carried out a systematic search of studies deposited in the Gene Expression Omnibus database through August 31, 2016. The present analyses included studies with: 1) patients with polycystic ovary syndrome and normal controls, 2) gene expression profiling of messenger RNA, and 3) sufficient data for our analysis. Ultimately, a total of 9 studies with 13 datasets met the inclusion criteria and were performed for the subsequent integrated analyses. Through comprehensive analyses, there were 13 genetic factors overlapped in all datasets and identified as significant specific genes for polycystic ovary syndrome. After quality control assessment, there were six datasets remained. Further gene ontology enrichment and pathway analyses suggested that differentially expressed genes mainly enriched in oocyte pathways. These findings provide potential molecular markers for diagnosis and prognosis of polycystic ovary syndrome, and need in-depth studies on the exact function and mechanism in polycystic ovary syndrome.